Afuco™ Anti-Human ICAM1 ADCC Therapeutic Antibody (BI-505), ADCC Enhanced
Anti-ICAM1 ADCC Enhanced Antibody (BI-505) is an ADCC enhanced antibody produced by our Afuco™ platform. BI-505 is a fully human high-affinity IgG1 antibody, which was isolated from a highly diverse human phage-antibody library based on its functional ability to induce programmed cell death of tumor cells. BI-505 binds to intercellular adhesion molecule-1 (ICAM-1), suggesting a previously unrecognized role for this receptor as a therapeutic target in cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-361CL |
| Pricing | Inquiry |
| Host | Human |
| Target | ICAM1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |